Propafenone Induced 1:1 Atrial Flutter Conduction
fibrillation (AF) a month prior to his admission at our institution. He underwent external cardioversion at that time and started on beta blocker, but that had to be discontinued soon
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
fibrillation (AF) a month prior to his admission at our institution. He underwent external cardioversion at that time and started on beta blocker, but that had to be discontinued soon
different VT-morphologies (VT1 and VT2) were easily induced via catheter manipulation. External cardioversion was performed twice to restore sinus rhythm due to unstable hemodynamic status during VT. Via antegrade
beats-per-minute (bpm) and electrocardiogram (ECG) demonstrated ventricular tachycardia (VT). Synchronized electrical cardioversion was performed to sinus bradycardia. He was stabilized and admitted to the hospital…
effect on blockade sodium channel. In this case, it allowed the pharmacological cardioversion into sinus rhythm, avoiding the postponement of the surgery. Further investigation should be conducted to confirm
reverted spontaneously. The latter, however, was refractory to vagal man oeuvres, adenosine and electrical cardioversion. Sinus rhythm was restored following an intravenous infusion of amiodarone
with a rate of 230 beats per minute. He received eleven direct current cardioversion treatments. He was initially started on Amiodarone, which was changed to Lidocaine later as he continued
females should be considered for anti-coagulation. . Other measures are rate control, cardioversion and ablate therapy including pace & ablate
first to describe a case involving acute PE presenting as hemodynamically unstable AVNRT requiring cardioversion
Despite many drugs that are currently available in preventing recurrences of AF after successful cardioversion to normal sinus rhythm, their efficacy remains unsatisfactory, with a great number of recurrences
associated with future AF development in 6.5 years. Also CRP levels can predict successful cardioversion rate in patients with AF. The other imflamatuar biomarkers are C3, C4 and interleukin
Molecular Weight Heparin prophylaxis (Seleparine 6000 UI tid). Initially, there was a successful pharmacological cardioversion, but after some days atrial fibrillation reappeared (150 bpm). At the 33 gestational week…
COPD was also found to be an independent predictor for a successful electro-cardioversion. These patients were also found to have an increased incidence of non-PV foci
with Streptokinase. He had two episodes of Ventricular fibrillation, which were reverted with direct cardioversion and was given Amiodarone infusion. After 6 hours, patient was started on injection Low molecular
Adenosine was given five times ?with increment doses- without resolution of the SVT. Electrical cardioversion followed and the SVT converted to normal sinus rhythm at 165/min after the second
admitted following a modified Davids reimplantation procedure. One hour later, ventricular fibrillation required 9 cardioversions to restore sinus rhythm. ECG showed a 2 mm elevation in V3. Coronary angiography showed
Amiodarone is a Class III antiarrhythmic agent used for cardioversion and prevention of recurrences of atrial fibrillation. However, its use is limited due to its side-effects resulting from
blocker, Ventricular Tachycardia (VT) and Ventricular Fibrillation (VF) had been occupied frequently and cardioversion was performed 63 times
mmHg and electrocardiogram showed atrial fibrillation with a rapid ventricular response. Synchronized electrical cardioversion was provided and amiodarone was administered. The heart returned back to normal sinus rhythm
Blockers used empirically to prevent the tacycardia .AF can be managed with digoxin or cardioversion .Serial echoes are used to follow cardiac function objectively Surgical management: Surgical commissurotomy
For authors and organisers
Find the right journal for your paper and submit your manuscript.